依贝沙坦治疗依从性良好，无过度副作用。
Irbesartan therapy was well tolerated and was not associated with an excess of any side effects.
组为观察组，予常规治疗基础上加厄贝沙坦和人胰岛素；
The observed group(group A) was given Irbesartan plus human insulin besides basic treatment.
目的：观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
目的评价厄贝沙坦联合索他洛尔治疗阵发性心房纤颤的效果。
ObjectiveTo investigate the effect of combination of irbesartan and sotalol in patients with paroxysmal atrial fibrillation.
厄贝沙坦另有重要的肾脏保护作用，可延迟糖尿病肾病的发生。
It was also demonstrated that irbesartan had the renal protective effects and could reduce the progression of diabetic nephropathy.
目的为了探讨原发性高血压患者伊贝沙坦降压疗效的影响因素。
Objective to evaluate the risk factors of Irbesartan in treatment of essential hypertension and to explore individualized antihypertensive treatment.
目的探讨厄贝沙坦联合胺碘酮治疗高血压病伴心房颤动的临床效果。
Objective To discuss the clinical curative effect of Irbesartan combined with Amiodarone in treating hypertension complicated with paroxysmal atrial fibrillation.
目的：探讨厄贝沙坦在治疗轻、中度高血压时对心血管相关因素的影响。
Objective To evaluate the effects of Irbesartan treatment on the relative factors of cardiovascular of low or moderate hypertension.
目的探讨伊贝沙坦对原发性高血压(EH)患者血管内皮功能的保护作用。
Objective it is to discuss the protection of Irbesartan on endothelial function of blood vessel in patients with essential hypertension (EH).
目的：建立以HPLC -荧光检测法测定人血浆中厄贝沙坦浓度的方法。
OBJECTIVE: To determine plasma concentration of irbesartan by HPLC with fluorescence detection.
本发明公开了一种厄贝沙坦氢氯噻嗪胶囊及其制备方法，属于医药技术领域。
The invention discloses an irbesartan hydrochlorothiazide capsule and a preparation method thereof, belonging to the technical field of medicines.
结论厄贝沙坦联合氢氯噻嗪疗效好，是治疗重度高血压安全有效的方法之一。
Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia.
目的观察厄贝沙坦对原发性高血压患者阵发性心房纤颤及其左心房大小的影响。
Objective To observe the effect of Irbesartan on hypertension patients with paroxysmal atrial fibrillation and left atrial size.
目的：比较伊贝沙坦和氯沙坦治疗轻中度高血压病的临床疗效、安全性及治疗依从性。
Objective: to compare the effects, safety and therapeutic dependence of irbesartan with that of losartan on mild-to-moderate essential hypertension.
目的比较伊贝沙坦与卡托普利治疗老年慢性心力衰竭(CHF)的临床疗效及安全性。
Objective to compare the clinical efficacy and safety of irbesartan with that of captopril in the treatment for elderly patients with congestive heart failure (CHF).
结论厄贝沙坦联合氢氯噻嗪降压以及逆转左心室肥厚的临床效果比单用厄贝沙坦更好。
Conclusion Irbesartan combined with hydrochlorothiazide effect on lowering the blood pressure and reversing of left ventricular hypertrophy is better than the single-use.
结论与氨氯地平相比，伊贝沙坦不仅在降压上有明显疗效，而且有较好的安全性和耐受性。
Conclusion Compared with amlodipine, irbesartan not only has obvious effect on lowering blood pressure, but also has better safety and toleration.
目的：评价伊贝沙坦合用依那普利对原发性高血压患者早期肾功能损害的有效性和安全性。
AIM: To evaluate the efficacy and safety of the combination of irbesartan and enalapril in treating renal damage in hypertensive patients.
结论综合考虑，厄贝沙坦片与氢氯噻嗪片联合应用是治疗单纯性收缩期高血压的最佳方案。
CONCLUSION Taking everything into consideration, Irbesartan combined with Hydrochlorothiazide was the best scheme in the treatment of the pure systolic hypertension.
目的比较厄贝沙坦与硝苯地平缓释片或氢氯噻嗪片联合治疗单纯性收缩期高血压的经济效果。
OBJECTIVE to compare the cost-effectiveness between Irbesartan combined with Extended Release Nifedipine or Hydrochlorothiazide in the treatment of the Pure Systolic Hypertension.
目的我们研究直接肾素抑制剂阿利吉仑的抗蛋白尿作用是否与依贝沙坦相当及两者联合的效果。
OBJECTIVE We investigated whether the antiproteinuric effect of the direct renin inhibitor aliskiren is comparable to that of irbesartan and the effect of the combination.
探讨自发性高血压大鼠(SHR)颈动脉血管间质胶原重构的特点及应用厄贝沙坦逆转的意义。
To investigate the characteristics of vascular collagen remodeling of the carotid artery and significance of irbesartan to reverse the effect in spontaneous hypertension rats (SHRs).
目的研究卡维地洛、厄贝沙坦及二者合用对急性心肌梗死(ami)大鼠胶原网络重构的影响。
Objective To investigate the effects of carvedilol, irbesartan and their combination on myocardial collagen network remodeling after acute myocardial infarction (AMI) in rats.
结论：常规治疗联合厄贝沙坦治疗慢性心衰，可进一步获得有益的疗效，并且有良好的安全性及耐受性。
Conclusion: Irbesartan combined with conventional treatment of chronic heart failure has further beneficial effect, and has a good safety and tolerability.
我们比较了最大推荐剂量的阿利吉仑、依贝沙坦及两者联合应用在2型糖尿病和蛋白尿患者的抗蛋白尿作用。
We compared the antiproteinuric effect of maximal recommended doses of aliskiren, irbesartan, and the combination in patients with type 2 diabetes and albuminuria.
目的探讨曲美他嗪联合厄贝沙坦治疗高血压病伴阵发性房颤的疗效及对左房内径、C反应蛋白(crp)的影响。
Objective To investigate the effect of trimetazidine combined with irbesartan on left atrial diameter and C-reactive protein (CRP) in hypertension patients with paroxysmal atrial fibrillation (PAF).
目的探讨厄贝沙坦联合阿托伐他汀对合并阵发性心房颤动(PAF)的急性心肌梗死(ami)患者心房颤动复发的防治作用。
Objective to evaluate the effect of irbesartan combined with atorvastatin on relapse of paroxysmal atrial fibrillation (PAF) in patients with acute myocardial infarction (AMI) complicated by PAF.
结论厄贝沙坦联合索他洛尔转复阵发性心房颤动，预防心房颤动发作的疗效显著优于单用索他洛尔，并有延缓左心房扩大的作用。
ConclusionThe combination of irbesartan and sotalol is more effective than sotalol alone for sinus rhythm maintenance and may restrain the enlargement of the left atrium.
贝那普利及缬沙坦可有效减轻心房纤维化和心肌缝隙连接蛋白的重构。
Benazepril and valsartan can decreased the degree of atrial fibrosis and remodeling of Gap junction connexin effectively.
贝那普利及缬沙坦可有效减轻心房纤维化和心肌缝隙连接蛋白的重构。
Benazepril and valsartan can decreased the degree of atrial fibrosis and remodeling of Gap junction connexin effectively.
应用推荐